EDITIONEN·FR·ქართ

Accréditation Sans Frontières

International Accreditation of Healthcare Facilities

Accréditation Sans Frontières · ASF Health Standards 9.0

Standard 10 · Organ & Tissue Transplant

6 criteria · base standard

Base standard. 6 criteria, of which 3 non-negotiable. Each criterion is numbered 10.Y, with its classification and verification questions.

Criteria

10.1 Donor Consent Obtained Through a Process Independent of the Transplant Team

NON-NEGOTIABLE

Donor or donor-family consent for organ or tissue donation is obtained through a process independent of the transplant team requesting the organ, with the independence structurally built in — not a theoretical separation undermined by the same staff being involved in both roles.

VERIFICATION QUESTIONS

  1. Is the person obtaining consent organisationally separate from the transplant team, not just nominally distinct while reporting to the same leadership?
    A structural, not just a titular, separation is what protects against conflict of interest.
  2. Is there a documented process ensuring the family or donor is never approached by someone with a direct stake in the transplant outcome?
    The specific person requesting consent should have no personal or professional interest in a "yes" answer.
  3. Can staff describe this separation clearly and confidently when asked?
    If staff cannot articulate how the separation works, it may not be built into practice.

10.2 Organ Allocation Follows a Transparent, Documented Protocol

NON-NEGOTIABLE

Organ allocation decisions follow a written, transparent protocol based on clinical criteria, applied consistently, with any deviation from the standard protocol specifically documented and justified — not informal decisions vulnerable to undue influence.

VERIFICATION QUESTIONS

  1. Does a written protocol govern allocation decisions, not informal judgement applied case by case?
    A written, consistent protocol is a specific, checkable safeguard against undue influence.
  2. Is any deviation from the standard protocol specifically documented with a clear clinical justification?
    An undocumented deviation is a specific, checkable gap that undermines the protocol's purpose.
  3. Is the allocation protocol and decision record available for independent review?
    Transparency means a decision can be reviewed, not just exist on paper.

10.3 No Financial Incentive to Donor or Family

NON-NEGOTIABLE

No financial payment or material incentive, beyond legitimate reimbursement of documented direct costs, is offered to a donor or donor family in connection with organ or tissue donation, with staff trained to recognise and refuse any such arrangement.

VERIFICATION QUESTIONS

  1. Is there a clear, written policy explicitly prohibiting financial incentive beyond legitimate documented cost reimbursement?
    A specific, written prohibition, not an assumed understanding.
  2. Are staff trained to recognise what counts as a legitimate reimbursement versus a prohibited incentive?
    The distinction needs to be concrete and understood, not left to individual judgement in the moment.
  3. Is there a documented process for reporting any suspected violation of this policy?
    An actionable reporting pathway, not just a policy statement with no mechanism behind it.

10.4 Recipient Evaluation and Informed Consent Process

CORE

Transplant recipients undergo a documented evaluation against clinical eligibility criteria, with informed consent covering realistic outcomes, risks, and the source of the organ or tissue where legally and clinically relevant — not a general surgical consent treated as sufficient.

VERIFICATION QUESTIONS

  1. Is recipient evaluation against clinical eligibility criteria documented, not assumed from referral alone?
    A referral for transplant evaluation is not the same as a documented eligibility determination.
  2. Does informed consent cover realistic outcomes and risks specific to transplant, not a generic surgical consent form?
    Transplant carries specific risks and realistic outcome ranges that a generic surgical consent does not address.
  3. Is the recipient's understanding verified, not just a signature obtained?
    A signature confirms a form was signed, not that the content was understood.

10.5 Organ and Tissue Traceability, End to End

CORE

Every organ or tissue is traceable through a documented chain of custody from donor to recipient, including handling, testing, and transport, with no gap in the record at any point in that chain.

VERIFICATION QUESTIONS

  1. Is there an actual, continuous chain of custody record, with no gap at any handling point?
    A single gap in the chain undermines the entire traceability purpose.
  2. Does the record include testing and screening results specific to that organ or tissue, not just a general log entry?
    Specific, retrievable results, not a generic pass/fail note.
  3. Can the full chain be reconstructed on request for a specific organ or tissue?
    Retrievable on demand, not theoretically traceable but practically difficult to reconstruct.

10.6 Post-Transplant Follow-Up and Outcome Tracking

STANDARD

Transplant recipients are followed systematically after the procedure, with graft and patient outcomes tracked and reported, not lost to follow-up once the recipient is discharged from the immediate post-operative period.

VERIFICATION QUESTIONS

  1. Is there a documented, systematic follow-up schedule, not informal contact depending on the recipient's own initiative?
    A proactive schedule, not reliance on the recipient to seek follow-up themselves.
  2. Are graft and patient outcomes tracked and aggregated, not scattered across individual, unconnected patient files?
    Aggregated tracking enables the programme to monitor its own outcomes over time.
  3. Is there a documented process for what happens when a recipient is lost to follow-up?
    A specific, active process for re-engagement, not simply accepting the loss. ————————————————————

← All ASF Health Standards

© 2026 Accréditation Sans Frontières · PHIG · Sheni Network